Home > Boards > US Listed > Biotechs > Avid Bioservices Inc. (CDMO)

Many stocks did not hold their large %

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
north40000 Member Profile
Member Level 
Followed By 195
Posts 16,222
Boards Moderated 0
Alias Born 01/19/06
160x600 placeholder
Annual Report (10-k) Edgar (US Regulatory) - 6/30/2020 5:02:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/30/2020 4:24:25 PM
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2020 and Recent Developments GlobeNewswire Inc. - 6/30/2020 4:05:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2020 5:20:36 PM
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2020 After Market Close on June 30, ... GlobeNewswire Inc. - 6/23/2020 4:05:10 PM
Avid Bioservices Names Nicholas Green as President and Chief Executive Officer GlobeNewswire Inc. - 6/23/2020 8:05:10 AM
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock GlobeNewswire Inc. - 6/3/2020 4:05:10 PM
Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution ... GlobeNewswire Inc. - 5/6/2020 8:05:10 AM
Avid Bioservices Announces Appointment of Two Senior Directors of Business Development with Responsibility for North America,... GlobeNewswire Inc. - 4/13/2020 8:05:10 AM
Avid Bioservices Receives Five 2020 CMO Leadership Awards GlobeNewswire Inc. - 3/26/2020 8:05:10 AM
Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2020 and Recent Developments GlobeNewswire Inc. - 3/10/2020 4:05:10 PM
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock GlobeNewswire Inc. - 3/4/2020 4:05:10 PM
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2020 After Market Close on March 10, 2020 GlobeNewswire Inc. - 3/3/2020 4:05:10 PM
Avid Bioservices Appoints Timothy Compton as Chief Commercial Officer GlobeNewswire Inc. - 1/8/2020 8:05:10 AM
Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2020 and Recent Developments GlobeNewswire Inc. - 12/9/2019 4:05:10 PM
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock GlobeNewswire Inc. - 12/4/2019 4:05:10 PM
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2020 After Market Close on December 9, 2019 GlobeNewswire Inc. - 12/2/2019 8:05:10 AM
Avid Bioservices Names Richard Richieri as Chief Operations Officer GlobeNewswire Inc. - 10/9/2019 12:30:00 PM
Avid Bioservices Announces Completion of Expansion of Process Development Capabilities and Laboratory Infrastructure GlobeNewswire Inc. - 10/8/2019 8:05:00 AM
Avid Bioservices Announces Termination of Stockholder Rights Plan GlobeNewswire Inc. - 9/23/2019 4:05:00 PM
Avid Bioservices Reports Financial Results for First Quarter Fiscal 2020 and Recent Developments GlobeNewswire Inc. - 9/5/2019 4:05:00 PM
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock GlobeNewswire Inc. - 9/4/2019 4:05:00 PM
Avid Bioservices to Report Financial Results For First Quarter of Fiscal Year 2020 After Market Close on September 5, 2019 GlobeNewswire Inc. - 8/29/2019 8:05:00 AM
Avid Bioservices Announces Appointment of Catherine Mackey, Ph.D. to Board of Directors GlobeNewswire Inc. - 7/26/2019 8:05:00 AM
north40000 Member Level  Tuesday, 05/26/20 07:31:18 PM
Re: stoneroad post# 333947
Post # of 334546 
Many stocks did not hold their large % gains they started with today, including the two we have been most interested in—AMRN and CDMO. Even NVDA and NVAX wound up less positive. For some, the initial excitement generated about the economy and Main Street getting back in the groove did not last the day, despite PR news from MRK and NVAX about their respective virus vaccines. Cramer even put IPIX( a rather consistent loser for me) in his trust portfolio, predicated on its PR that its compound(like those of AMRN and CDMO) is in trials to determine usefulness in reducing effect and aiding quicker recovery from Corona virus infection.

I have no really logical explanation for today’s disparate portfolio results.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist